United Kingdom
University of Cambridge - Cambridge Institute for Therapeutic Immunology and Infectious Disease
COVID, Long COVID, SARS-CoV-2, T cell assay, Interleukin-2, Interferon gamma, SARS-CoV2 antibodies/serology
SARS-CoV-2, primary human bronchial epithelial cells, ACE2, air-liquid interface, cigarette smoke extract
Human cytomegalovirus, Proteomics, systems virology, necroptosis, cell death, Host-pathogen interaction, transcriptional regulation